Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-22

Clinical Trial Update: Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pyronaridine-artesunate 3:1 granules to crushed Coartem tablets in pediatric Plasmodium falciparum malaria; study completed with posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coartem (artemether-lumefantrine)
  • Pyronaridine Artesunate 3:1 Granule Formulation

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 3 | Status: COMPLETED | Results posted: 2021-11-22